Keyphrases
Clinical Presentation
100%
Neurological Involvement
100%
Farber Disease
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
60%
Stem Cell Transplantation
60%
Granuloma
40%
Joint Contracture
40%
Clinical Phenotype
20%
Graft-versus-host Disease (GvHD)
20%
Busulfan
20%
Therapy-related
20%
Dysregulation
20%
Late Sequelae
20%
Immune System
20%
Motility
20%
Neurological Status
20%
Leukocytes
20%
Ceramide
20%
Respiratory Insufficiency
20%
Respiratory Tract
20%
Myeloablative
20%
Subcutaneous Nodules
20%
Unrelated Donor
20%
Lysosomal Storage Disease
20%
Donor chimerism
20%
Preparative Regimen
20%
Stem Cell Source
20%
Living Donor
20%
Interstitial Pneumonitis
20%
Complete Resolution
20%
Acid Ceramidase
20%
Neurological Findings
20%
Short Course
20%
GVHD Prophylaxis
20%
Neurotoxic Effects
20%
Periarticular
20%
Granuloma Formation
20%
Joint Deformation
20%
Progressive Deterioration
20%
Breathy Voice
20%
Medicine and Dentistry
Farber Disease
100%
Allogeneic Hematopoietic Stem Cell Transplantation
60%
Granuloma
60%
Stem Cell Therapy
40%
Disease
20%
Stem Cell
20%
Methotrexate
20%
Sequela
20%
Leukocyte
20%
Immune System
20%
Deterioration
20%
Respiratory Failure
20%
Infancy
20%
Ceramide
20%
Subcutaneous Nodule
20%
Lysosomal Storage Disease
20%
Chimera
20%
Busulfan
20%
Chronic Graft Versus Host Disease
20%
Storage Disease
20%
Idiopathic Interstitial Pneumonia
20%
Acid Ceramidase
20%
Contracture
20%
Joint Contracture
20%
Joint Mobility
20%
Patient History of Stem Cell Transplantation
20%
Immunology and Microbiology
Allogeneic Hematopoietic Stem Cell Transplantation
100%
Stem Cell Transplantation
100%
Granuloma
100%
Stem Cell
33%
Methotrexate
33%
Immune System
33%
Leukocyte
33%
Infancy
33%
Pneumonitis
33%
Chimera
33%
Chronic Graft Versus Host Disease
33%
Joint Mobility
33%